Johnson & Johnson (NYSE:JNJ)
| 162.71 BATS BZX Real-Time Price As of 11:12am ET |  -0.07 / -0.04%Today’s Change | 109.16 Today|||52-Week Range 164.14 | +3.39% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 162.78 |
| Today’s open | 163.25 |
| Day’s range | 161.80 - 164.14 |
| Volume | 1,745,781 |
| Average volume (3 months) | 7,075,507 |
| Market cap | $422.0B |
Data as of 11:12am ET, 01/20/2021
Growth & Valuation
| Earnings growth (last year) | +0.28% |
| Earnings growth (this year) | -7.81% |
| Earnings growth (next 5 years) | +5.75% |
| Revenue growth (last year) | +0.71% |
| P/E ratio | 25.6 |
| Price/Sales | 4.76 |
| Price/Book | 7.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.05 | -0.05% |
| MRKMerck | -0.02 | -0.02% |
| PFEPfizer | -0.13 | -0.37% |
| ABBVAbbVie | +0.44 | +0.39% |
Data as of 11:12am ET, 01/20/2021
Financials
| Next reporting date | January 26, 2021 |
| EPS forecast (this quarter) | $1.82 |
| Annual revenue (last year) | $82.1B |
| Annual profit (last year) | $15.1B |
| Net profit margin | 18.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
